Image Analysis | Tissuepathology.com

Indica Labs Announces Webinar for November

Erica Goodpaster — Wed, 21 Oct 2026 10:51:31 +0000

Indica Labs: Learn About AI Model Interoperability with HALO AI Open AI Workflows in Digital Pathology: Model Interoperability with HALO® Date: 4 November 2026 Time: 8:00 – 9:00 PST | 11:00 – 12:00 EST | 16:00 – 17:00 GMT Location: Webinar Register Now Summary As artificial intelligence becomes increasingly integrated into digital pathology, interoperability between […]

The post Indica Labs Announces Webinar for November first appeared on Tissuepathology.com.

HistoIndex and A*STAR Partner To Advance Early – Stage Development Of Pipeline Therapies For Fibrotic Diseases

Erica Goodpaster — Tue, 20 Oct 2026 12:52:38 +0000

[SINGAPORE, October 19th, 2026] – /PR Newswire/ HistoIndex, a pioneer in AI-driven digital pathology for fibrotic diseases, and the Agency for Science, Technology and Research (A*STAR), Singapore’s lead public sector R&D agency, have signed a Memorandum of Understanding (MoU) to collaborate on the preclinical evaluation and characterization of therapeutic candidates for various fibrotic diseases, including […]

The post HistoIndex and A*STAR Partner To Advance Early – Stage Development Of Pipeline Therapies For Fibrotic Diseases first appeared on Tissuepathology.com.

Tempus Presents Data Demonstrating AI-Enabled Pre-Screening Can Help Identify Patients for Biomarker Testing in NSCLC

Erica Goodpaster — Mon, 19 Oct 2026 12:41:31 +0000

Tempus: Study presented at ESMO evaluated more than 60,000 advanced NSCLC cases and found greater than 80% sensitivity across all 12 biomarkers using routine H&E pathology images CHICAGO–(BUSINESS WIRE)–Tempus AI, Inc. (NASDAQ: TEM) today announced results from a study evaluating an AI-enabled pre-screening panel for patients with advanced non-small cell lung cancer (NSCLC). The panel […]

The post Tempus Presents Data Demonstrating AI-Enabled Pre-Screening Can Help Identify Patients for Biomarker Testing in NSCLC first appeared on Tissuepathology.com.

Indica Labs and NeoGenomics Expand AI Leadership Through Enterprise Digital Pathology Partnership

Erica Goodpaster — Fri, 16 Oct 2026 11:41:44 +0000

ALBUQUERQUE, N.M, October 15, 2026 — Indica Labs, the trusted global leader in AI-powered digital pathology, today announced a significant expansion of its strategic partnership with NeoGenomics, a leading provider of oncology diagnostic solutions that enable precision medicine. The expanded collaboration is intended to modernize NeoGenomics enterprise digital pathology infrastructure, accelerate the evaluation and adoption […]

The post Indica Labs and NeoGenomics Expand AI Leadership Through Enterprise Digital Pathology Partnership first appeared on Tissuepathology.com.

Aiforia sets a new benchmark with the release of Aiforia® Create 8.0

Erica Goodpaster — Thu, 15 Oct 2026 15:31:04 +0000

Aiforia® Create 8.0 makes AI model development even faster, smoother, and more intuitive than before. Aiforia Technologies Plc today announces the global market release of Aiforia® Create version 8.0, setting a new industry standard for AI model development in digital pathology. Designed for pathologists, researchers, and other domain experts, Aiforia® Create is the most versatile […]

The post Aiforia sets a new benchmark with the release of Aiforia® Create 8.0 first appeared on Tissuepathology.com.

OptraSCAN to Unveil the FDA-Cleared OS-Ultra Scanner at Pathology Visions 2026

Erica Goodpaster — Wed, 14 Oct 2026 13:19:59 +0000

OptraSCAN: The whole slide scanner will make its first public appearance at booth 417, following its clearance. Available starting in December. SAN JOSE, CA, UNITED STATES, October 13, 2026 /EINPresswire.com/ — SAN JOSE, Calif., Oct. 13, 2026 — OptraSCAN, Inc. today announced it will unveil the FDA-cleared OS-Ultra whole slide scanner at the Digital Pathology […]

The post OptraSCAN to Unveil the FDA-Cleared OS-Ultra Scanner at Pathology Visions 2026 first appeared on Tissuepathology.com.